FilingSEC EDGAR8-K
Enanta Pharmaceuticals Announces CEO Retirement and Appointment of New COO
· SEC accepted
StageManagement Change
Filing content
CEO Jay R. Luly plans to retire by February 1, 2027, and the company has initiated a search for his successor. Additionally, Dr. Tara L. Kieffer has been appointed as the new Chief Operating Officer.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…